Do not prefer intravenous antibiotic formulations over oral ones if, after 48 hours of therapy, the patient (both pediatric and adult) meets the criteria for IV-to-oral switch, namely: afebrile, able to take oral medication, showing clinical improvement, and not affected by deep bacterial infections at high risk. (Green recommendation)
Numerous scientific studies have shown, and several guidelines (NICE, WHO) recommend, that intravenous antibiotic therapy should be promptly switched to oral therapy once the IV-to-oral (IV-PO) switch criteria are met—or discontinued if no longer necessary. The...
Do not use continuous glucose monitoring systems in patients with type 2 diabetes who are not treated with insulin.
Current evidence on continuous glucose monitoring (CGM) in type 2 diabetes is limited and of low quality. Available studies suggest only a modest improvement in HbA1c levels with CGM, without an increased risk of hypoglycemia. There is no robust evidence to support...
Do not use implantable loop recorders in asymptomatic patients at high risk of stroke as a screening tool for atrial fibrillation.
The clinical impact of diagnosing atrial fibrillation (AF) in asymptomatic individuals through screening programs remains not fully established, as current literature has not consistently demonstrated a reduction in thrombotic events. Furthermore, the patient...
Do not postpone the start of a shared care planning with the patient, when the evolution of the disease makes it important to understand the expectations and desires of the sick person regarding possible choices at the end of life.
Shared planning of care is provided for by Law 219/2017 “Rules on Informed Consent and Advance Treatment Provisions”. It allows the sick person, if desired, and the treating physician to align themselves on the goals of care, on futile or disproportionate...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments